Drug Shortage Report for SANDOZ TOLTERODINE LA
Report ID | 255907 |
Drug Identification Number | 02413159 |
Brand name | SANDOZ TOLTERODINE LA |
Common or Proper name | TOLTERODINE LA |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TOLTERODINE TARTRATE |
Strength(s) | 4MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100PRCH |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2025-04-28 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-05-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-05-12 | French | Compare |
v4 | 2025-05-12 | English | Compare |
v3 | 2025-04-29 | English | Compare |
v2 | 2025-04-28 | French | Compare |
v1 | 2025-04-28 | English | Compare |
Showing 1 to 5 of 5